Publications by authors named "Terrell A Patterson"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,410

Total Likes

146

Extended Reach

293,516

Social Features

53
A
A 1-year analysis from a natural history study in Chinese individuals with Duchenne muscular dystrophy.
Xihua Li, Junlan Lv, Wenhua Zhu, Siqi Hong, Zhiqiang Wang, Terrell A Patterson

Lancet Reg Health West Pac· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]).
Alan B Miller, James L Januzzi, Blair J O'Neill, Balarama Gundapaneni, Terrell A Patterson

Am J Cardiol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study.
Thibaud Damy, Pablo Garcia-Pavia, Mazen Hanna, Daniel P Judge, Giampaolo Merlini, Terrell A Patterson

Eur J Heart Fail· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Mazen Hanna, Thibaud Damy, Martha Grogan, Michelle Stewart, Balarama Gundapaneni, Terrell A Patterson

Am J Cardiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
Claudio Rapezzi, Perry Elliott, Thibaud Damy, Jose Nativi-Nicolau, John L Berk, Terrell A Patterson

JACC Heart Fail· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bioequivalence of Tafamidis 61-mg Free Acid Capsules and Tafamidis Meglumine 4 × 20-mg Capsules in Healthy Volunteers.
Peter A Lockwood, Vu H Le, Melissa T O'Gorman, Terrell A Patterson, Marla B Sultan

Clin Pharmacol Drug Dev· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a Mathematical Model of Rat Body Weight Regulation in Application to Caloric Restriction and Drug Treatment Studies.
Jangir Selimkhanov, W Clayton Thompson, Terrell A Patterson, John R Hadcock, Dennis O Scott

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
Benjamin S Maciejewski, Jennifer L LaPerle, Danny Chen, Avijit Ghosh, William J Zavadoski, Terrell A Patterson

Am J Physiol Gastrointest Liver Physiol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor.
Michael Fichtner, Eunsun Lee, Elizabeth Tomlinson, Dennis Scott, Peter Cornelius, Terrell A Patterson

Bioorg Med Chem Lett· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.
Kevin K-C Liu, Bruce A Lefker, Mark A Dombroski, Phoebe Chiang, Peter Cornelius, Terrell A Patterson

Bioorg Med Chem Lett· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.
Kevin K-C Liu, Peter Cornelius, Terrell A Patterson, Yuan Zeng, Stephanie Santucci

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food intake in rhesus monkeys following central administration of orexins.
Jon J Ramsey, Joseph W Kemnitz, Wendy Newton, Kevork Hagopian, Terrell A Patterson

Regul Pept· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics.
Robert L Dow, Steven R Schneider, Ernest S Paight, Richard F Hank, Phoebe Chiang, Terrell A Patterson

Bioorg Med Chem Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist.
Richard L Elliott, Robert M Oliver, Marlys Hammond, Terrell A Patterson, Li She

J Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis